NEXT Oncology

Running trials

• Recruiting

  Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

  NCT07755436· Phase 1· Source

• Recruiting

  AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

  NCT07454642· Phase 1· Source

• Recruiting

  A 2-part Phase 1/2 Open-label Trial on ODM-212

  NCT07563738· Phase 1/2· Source

• Active, not recruiting

  Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

  NCT06334432· Phase 1/2· Source

• Active, not recruiting

  A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

  NCT05787587· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Pancreatic cancer2 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Mesothelioma1 recruiting
• Ovarian cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

  NCT05975073· Phase 1/2· Source

• Terminated

  Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.

  NCT05831995· Phase 1· Source

• Completed

  A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

  NCT05753722· Phase 1· Source